Penbrook Management LLC Has $1.85 Million Stake in Viemed Healthcare, Inc. $VMD

Penbrook Management LLC lifted its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 51.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 272,328 shares of the company’s stock after buying an additional 92,308 shares during the quarter. Viemed Healthcare comprises about 1.3% of Penbrook Management LLC’s holdings, making the stock its 16th largest position. Penbrook Management LLC owned 0.70% of Viemed Healthcare worth $1,849,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of VMD. AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the 1st quarter valued at about $90,000. Cardinal Point Capital Management ULC bought a new position in shares of Viemed Healthcare during the 2nd quarter worth approximately $128,000. Intech Investment Management LLC boosted its position in Viemed Healthcare by 14.4% in the second quarter. Intech Investment Management LLC now owns 18,612 shares of the company’s stock worth $129,000 after purchasing an additional 2,349 shares during the last quarter. Invesco Ltd. increased its holdings in Viemed Healthcare by 25.5% during the second quarter. Invesco Ltd. now owns 18,652 shares of the company’s stock worth $129,000 after buying an additional 3,795 shares during the last quarter. Finally, Marshall Wace LLP purchased a new stake in shares of Viemed Healthcare during the 2nd quarter worth approximately $147,000. Institutional investors own 74.24% of the company’s stock.

Analyst Ratings Changes

VMD has been the topic of several research reports. Wall Street Zen raised shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 15th. Weiss Ratings reissued a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $7.25 on Wednesday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.01 and a current ratio of 1.13. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $8.61. The firm has a market cap of $275.65 million, a PE ratio of 21.97 and a beta of 1.25. The business has a 50 day moving average price of $6.89 and a 200-day moving average price of $6.84.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. The business had revenue of $71.91 million during the quarter, compared to analysts’ expectations of $72.00 million. Viemed Healthcare had a net margin of 5.34% and a return on equity of 9.95%.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.